450 related articles for article (PubMed ID: 25833809)
41. Transoral robotic surgery: a 4-year learning experience in a single Danish Cancer Centre.
Isenberg AL; Channir HI; von Buchwald C; Rubek N; Friborg J; Kiss K; Charabi BW
Acta Otolaryngol; 2020 Feb; 140(2):157-162. PubMed ID: 31849248
[No Abstract] [Full Text] [Related]
42. Oropharyngeal cancer treatment: the role of transoral surgery.
Hinni ML; Nagel T; Howard B
Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):132-8. PubMed ID: 25761152
[TBL] [Abstract][Full Text] [Related]
43. Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
Cracchiolo JR; Baxi SS; Morris LG; Ganly I; Patel SG; Cohen MA; Roman BR
Cancer; 2016 May; 122(10):1523-32. PubMed ID: 26970050
[TBL] [Abstract][Full Text] [Related]
44. The role of surgery for HPV-associated head and neck cancer.
Mydlarz WK; Chan JY; Richmon JD
Oral Oncol; 2015 Apr; 51(4):305-13. PubMed ID: 25456011
[TBL] [Abstract][Full Text] [Related]
45. Feasibility and safety of transoral robotic surgery (TORS) for early hypopharyngeal cancer: a subset analysis of the Hamburg University TORS-trial.
Lörincz BB; Busch CJ; Möckelmann N; Knecht R
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2993-8. PubMed ID: 25217079
[TBL] [Abstract][Full Text] [Related]
46. Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.
Baliga S; Kabarriti R; Jiang J; Mehta V; Guha C; Kalnicki S; Smith RV; Garg MK
Oral Oncol; 2018 Nov; 86():75-80. PubMed ID: 30409323
[TBL] [Abstract][Full Text] [Related]
47. The Patient Perspective: Evaluating the Accessibility of Transoral Robotic Surgery Online Resources.
Xing MH; Chai RL
Ann Otol Rhinol Laryngol; 2022 Jan; 131(1):27-38. PubMed ID: 33843290
[TBL] [Abstract][Full Text] [Related]
48. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
[TBL] [Abstract][Full Text] [Related]
49. Opioid Usage and Prescribing Predictors Following Transoral Robotic Surgery for Oropharyngeal Cancer.
Abt NB; Holcomb AJ; Feng AL; Suresh K; Mokhtari TE; McHugh CI; Parikh AS; Faden DL; Deschler DG; Varvares MA; Lin DT; Richmon JD
Laryngoscope; 2021 Jun; 131(6):E1888-E1894. PubMed ID: 33210756
[TBL] [Abstract][Full Text] [Related]
50. Transoral Robotic Surgery and De-escalation of Cancer Treatment.
Wahle B; Zevallos J
Otolaryngol Clin North Am; 2020 Dec; 53(6):981-994. PubMed ID: 32917423
[TBL] [Abstract][Full Text] [Related]
51. DNA-Pk
Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
[TBL] [Abstract][Full Text] [Related]
52. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption.
Li H; Torabi SJ; Park HS; Yarbrough WG; Mehra S; Choi R; Judson BL
Laryngoscope; 2019 Aug; 129(8):1844-1855. PubMed ID: 30575965
[TBL] [Abstract][Full Text] [Related]
53. [Transoral robotic surgery for head and neck cancer].
Channir HI; Isenberg AL; Rubek N; Lomholt AF; Scott SI; Tvedskov JF; Charabi BW; Buchwald CV
Ugeskr Laeger; 2018 Nov; 180(47):. PubMed ID: 30509345
[TBL] [Abstract][Full Text] [Related]
54. Upfront transoral robotic surgery (TORS)
Zorzi SF; Agostini G; Chu F; Tagliabue M; Pietrobon G; Corrao G; Volpe S; Marvaso G; Colombo F; Cossu Rocca M; Gandini S; Gaeta A; Ruju F; Alterio D; Ansarin M
Acta Otorhinolaryngol Ital; 2022 Aug; 42(4):334-347. PubMed ID: 35938555
[TBL] [Abstract][Full Text] [Related]
55. Safety and efficacy of concurrent neck dissection and transoral robotic surgery.
Kucur C; Durmus K; Gun R; Old MO; Agrawal A; Teknos TN; Ozer E
Head Neck; 2016 Apr; 38 Suppl 1():E519-23. PubMed ID: 25783843
[TBL] [Abstract][Full Text] [Related]
56. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
Smith RV; Schiff BA; Garg M; Haigentz M
Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
[TBL] [Abstract][Full Text] [Related]
57. Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
J Clin Oncol; 2022 Mar; 40(8):866-875. PubMed ID: 34995124
[TBL] [Abstract][Full Text] [Related]
58. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
Nichols AC; Yoo J; Hammond JA; Fung K; Winquist E; Read N; Venkatesan V; MacNeil SD; Ernst DS; Kuruvilla S; Chen J; Corsten M; Odell M; Eapen L; Theurer J; Doyle PC; Wehrli B; Kwan K; Palma DA
BMC Cancer; 2013 Mar; 13():133. PubMed ID: 23514246
[TBL] [Abstract][Full Text] [Related]
59. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma - A systematic review of the literature.
Yeh DH; Tam S; Fung K; MacNeil SD; Yoo J; Winquist E; Palma DA; Nichols AC
Eur J Surg Oncol; 2015 Dec; 41(12):1603-14. PubMed ID: 26461255
[TBL] [Abstract][Full Text] [Related]
60. The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
Tapia M; Manji J; Dhillon K; Kleid S; Flatman S; Prasad J; Cardin A; Fua T; Rischin D; Dixon B; J R Magarey M
Oral Oncol; 2022 Dec; 135():106213. PubMed ID: 36274346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
